Replies to post #103925 on Biotech Values

[DewDiligence]

The annual 13G-filing season is here again.* Blackrock just filed a 13G showing 2,566,349 shares of MNTA, which is down from 2,782,260 shares as of the previous filing (#msg-54286676):

http://sec.gov/Archives/edgar/data/1235010/000108636411003378/momentapharmace123110.txt

*The filing deadline for showing 12/31/10 holdings is 2/14/11.

[DewDiligence]

MNTA Major Shareholders

[Updated for annual Form-13G filings showing holdings on 12/31/10.]


The table below shows all shareholders who file on SEC Form 13G
and all insiders with a 1% equity stake (currently only Craig Wheeler).
The number shown for Wheeler includes restricted stock and options,
whether or not vested.

 
                            Shares    Stake* 
 Oppenheimer               5,004,764   8.6% 
 Novartis                  4,708,679   8.1% 
 Fidelity                  4,501,514   7.7% 
 Palo Alto Investors       3,315,742   5.7% 
 T Rowe Price              3,286,973   5.7% 
 Wellington                2,856,790   4.9% 
 BlackRock                 2,566,349   4.4% 
 Craig Wheeler (CEO)       1,013,281   1.7%

*Based on 58.2M diluted shares for valuation purposes (#msg-58118280);
thus, the % numbers in the table do not concur with those in SEC filings.